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Abstract
Background: Long-chain polyunsaturated fatty acids (LCPUFAs) reduce T-cell activation and dampen inflammation. They
might thereby counteract the neonatal immune activation and hamper normal tolerance development to harmless
environmental antigens. We investigated whether fatty acid composition of cord serum phospholipids affects allergy
development up to age 13 years.
Methods: From a population-based birth-cohort born in 1996/7 and followed until 13 years of age (n = 794), we selected
cases with atopic eczema (n = 37) or respiratory allergy (n = 44), as well as non-allergic non-sensitized controls (n = 48) based
on diagnosis at 13 years of age. Cord and maternal sera obtained at delivery from cases and controls were analysed for
proportions of saturated, monounsaturated and polyunsaturated fatty acids among serum phospholipids.
Results: The cord serum phospholipids from subject who later developed either respiratory allergy or atopic eczema had
significantly higher proportions of 5/8 LCPUFA species, as well as total n-3 LCPUFA, total n-6 LCPUFA and total LCPUFA
compared to cord serum phospholipids from controls who did not develop allergy (P,0.001 for all comparisons).
Conversely, individuals later developing allergy had lower proportion of the monounsaturated fatty acid 18:1n-9 as well as
total MUFA (p,0.001) among cord serum phospholipids. The risk of respiratory allergy at age 13 increased linearly with the
proportion of n-3 LCPUFA (Ptrend,0.001), n-6 LCPUFA (Ptrend = 0.001), and total LCPUFA (Ptrend,0.001) and decreased
linearly with the proportions of total MUFA (Ptrend = 0.025) in cord serum phospholipids. Furthermore, Kaplan-Meier
estimates of allergy development demonstrated that total LCPUFA proportion in cord serum phospholipids was significantly
associated with respiratory allergy (P = 0.008) and sensitization (P = 0.002), after control for sex and parental allergy.
Conclusion: A high proportion of long-chain PUFAs among cord serum phospholipids may predispose to allergy
development. The mechanism is unknown, but may involve dampening of the physiologic immune activation in infancy
needed for proper maturation of the infant’s immune system.
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Introduction
The prevalence of allergic diseases increased drastically in
industrialized countries during the 20th century. Although genetic
factors play a role, migration and adoption studies point to the
environment during the first year(s) of life as a major determinant
for the risk of allergy development [1]. A vast reduction in
exposure to microbes has occurred in the last 100 years and
allergy development has been linked to a paucity of early infections
[2] or an impoverished early gut microbiota [3]. These findings
suggest that the infant’s immune system needs to receive
stimulating signals in order to mature correctly. Such maturation
could be needed to develop the capacity to actively tolerize
harmless environmental antigens, ‘‘allergens’’.
Another observation is the link between an allergy and
replacement of butter by margarines and vegetable oils in the
diet [4–7]. Butter is rich in saturated fatty acids, while margarines
and oils are rich in polyunsaturated fatty acids (PUFAs). PUFAs
are immunomodulators foremost reducing T-cell proliferation [8–
10] and interferon-gamma production [11,12]. This is true for
both n-6 PUFAs [13–16], found mainly in margarine and
vegetable oils, and n-3 LCPUFAs [13,17,18], mainly found in
fish. As LCPUFAs are essential in foetal development, they are
actively and selectively transported across the placenta and the
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newborn infant has higher levels of several LCPUFAs than those
found in maternal serum [19].
The objective of this study was to investigate whether levels of
long-chain fatty acids in cord serum phospholipids are associated
with allergy development up to age 13 years. We speculated that if
LCPUFAs in the infant’s blood dampen the immune activation
afforded by microbial antigens during early infancy, high
LCPUFA levels might hamper immune maturation and develop-
ment of tolerance to innocuous antigens, leading to increased risk
of allergy development. To investigate this hypothesis, we
retrospectively analysed the fatty acid composition of cord sera
of individuals who developed allergy during childhood (cases) or
remained non-allergic (controls).
Methods
Birth cohort
A total of 129 cases and controls were chosen from a
population-based birth-cohort targeting all 1228 children born
vaginally during one year (1996–7) in the County of Ja¨mtland in
Northern Sweden [20] and followed until 13 years of age.
Prospective parents were recruited at gestational week 18 when
a detailed questionnaire was distributed. The children were
examined regarding sensitization to common food and inhalant
allergens by skin prick tests at 1 and 4 years of age and allergic
symptoms were reported by the parents through questionnaires
when the children were 1, 4, and 7 years old [20]. At 13 years of
age, families that still lived in the region received a new symptom
questionnaire. This was accepted by 841 families and returned by
834; 794 adolescents were skin prick tested. One nurse conducted
all prick tests for milk, egg, fish, wheat, soy, cat, dog, horse,
timothy grass, and birch using standardized extracts (ALK,
Ho¨rsholm, Denmark; 10 histamine equivalent prick units poten-
cy). Reproducibility was checked repeatedly according to interna-
tional recommendations [21].
Ethic statement
The study was conducted according to the Helsinki II
Declaration (http://www.wma.net/en/30publications/
10policies/b3/index.html) and was approved by the local ethical
committee in Umea˚, Sweden (Dnr 95–149, 09–017 M and 09–
110 M). Pregnant women were recruited in their gestational week
18. Participating was voluntary and those mothers who accepted
to participate in the study provided written consent forms
concerning collection of cord serum. Thirteen years later, on
behalf of the minors, parents of the adolescents provided a new
written consent form and the adolescents themselves approved
their participation orally for skin prick tests and for fatty acid
analyses in stored cord serum. As participation was voluntary,
adolescents were free to at any time, without any stated reason,
decide not to participate in further tests and questionnaires. All
potential participants who declined no further participation or
otherwise did not participate were not disadvantaged in any way
by their decision.
Collection of serum samples
Cord and maternal venous serum were obtained at delivery and
stored frozen at 220uC until analysed.
Allergy diagnosis
Study subjects were selected based on the clinical diagnosis at
13 years of age and included the following three diagnostic groups:
1) Respiratory allergy, defined as fulfilling $1 of the following
criteria; wheeze in the past year, doctor’s diagnosed asthma,
asthma inhalation treatment, or a positive answer to the
question: ‘‘Have you had any signs of pollen allergy or allergy
to furred pets during the last 12 months?’’ Further, at least
one positive reaction in the skin prick test was required and
the individual should have no other atopic diagnosis. In all,
139 adolescents fulfilled these criteria.
2) Atopic eczema, defined as pruritic, chronic or chronically
relapsing non-infectious dermatitis with typical features and
distribution, fulfilling three of the main criteria suggested by
Hanifin and Rajka [22]. Sensitisation was not required, but
the individual should display no other allergic disease
manifestation. In all, 79 adolescents fulfilled these criteria.
3) Non-allergic controls, defined as having neither allergic
symptoms, nor any positive reaction in the skin prick test at
13 years of age (n = 332).
Selecting subjects
From the three groups, we aimed to select approximately 50
subjects per group for fatty acid analysis of stored cord serum
samples. In the group with atopic eczema, however, only 40
subjects had sufficient amounts of sera stored for fatty acid
analysis; these were all included, but due to need for reanalysis
etc., 37 individuals remained in this group. For respiratory allergy
and non-allergic controls, we selected 50 individuals at random
and the final groups included 44 cases with respiratory allergy and
48 non-allergic, non-sensitized controls. The selected subjects were
not matched on any factors, but a post-hoc analysis was done to
test for skewness in the selection process. As seen in Table 1, there
were no significant differences between the randomly chosen
subjects and the diagnostic groups from which they derived.
Maternal consumption of fish during pregnancy
The questionnaire distributed to the pregnant mother at
gestational week 18 contained a question about how often they
consumed fish. A complete answer was received from 79 of the
129 mothers of the investigated subjects. Based on their responses,
the mothers were divided into three groups: those eating fish less
than twice a month (n = 18), those eating fish approximately twice
a month (n = 34) and those eating fish more than twice a month
(n = 27).
Analysis of serum phospholipids
The phospholipid fraction of cord and maternal sera obtained
at delivery were extracted and methylated by direct trans-
esterification [23]. Fat was extracted with chloroform: methanol
(1:2) and 0.5% NaCl-solution [24]. Phospholipids were obtained
by separation on amino propyl solid phase extraction columns
(Isolute NH2, 6 ml, 500 mg, IST, Mid Glamorgon, UK) [25] and
converted to methyl esters [23], during overnight incubation. The
methyl esters were then extracted with petroleum ether. After
evaporation, the phospholipids were dissolved in isooctane and
separated by gas chromatography (Hewlett Packard 5890,
Waldbronn, Germany). Detection was done by flame ionization
and the Borwin software (Le Fontanil, France) was used for
evaluation. The samples were separated by gas chromatography
on two different columns. First, the 129 samples were separated on
a HP Ultra 1 (50 m 60.32 mm 60.52 mm dF) silicon column
(J&W Scientific, California) suitable for separation of the 20–22
carbon atoms long fatty acids. The proportion of each of these
fatty acids was calculated as per cent of the total amounts of fatty
Cord Serum PUFAs Predict Allergy Development
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acids (16–22 carbon atoms long) based on peak area. Where
sufficient materials remained (85 samples), we also performed
separation of 16–18 carbon long fatty acids on a DB-WAX (30 m
60.25 mm 60.25 mm dF) column (J&W Scientific, California).
The proportions of these fatty acids were also expressed as
percentage of total fatty acids, i.e. all fatty acids 16–22 carbon
atoms long; the total amount of fatty acids is not dependent on
complete resolution between all the peaks in the chromatograms
and could, thus, be estimated from either of the columns.
Statistical analysis
Chi-tests were used for the background analysis to test for
differences between qualitative variables between groups, and for
trend analyses. Differences in fatty acid proportions were
compared between clinical groups using Mann–Whitney U test.
Spearman’s rank correlation was used to test the relation between
fatty acid proportions in maternal and cord serum phospholipids,
and between maternal fish intake and n-3 LCPUFA content in
maternal and cord serum phospholipids. IBM SPSS Statistics
version 19 (IBM Corporation, New York) was used.
Kaplan–Meier curves were calculated (IBM SPSS Statistics) to
follow allergy development over time in subjects grouped
according to cord LCPUFA levels. Cox regression was used to
control for confounders.
To identify confounders, we performed partial least square
(PLS), a regression variety of principal component analysis using
UnscramblerH X version 10.2 (CAMO Software AS, Oslo). The
advantage with PLS is that the variables need neither to be
normally distributed, nor independent from one another. The
clinical diagnosis consisted the response (Y) variable to which total
LCPUFA proportion in cord serum phospholipids and potential
confounders (sex, parental history of allergy, pregnancy length,
maternal proportions of total LCPUFAs in serum at delivery,
breastfeeding, older siblings and pets) were related. Confounders
found to be significant in the PLS regression model were then used
in the Cox-regressions.
Results
Adolescents who either had respiratory allergy (n = 44), or
atopic eczema (n = 37) or were non-allergic at 13 years of age
(n = 48) were selected from a population-based birth-cohort. The
characteristics of the diagnostic groups, as well as the individuals
selected from each group, are shown in Table 1. Parental allergy
was more common among allergic individuals, while pet-keeping
during the 1st year of life was less common in adolescents with
respiratory allergy, compared to non-allergic ones (Table 1). This
is in accordance with our previous reports from this cohort [20].
As seen from the table, selected adolescents differed little from the
groups from which they derived, suggesting that no major
skewness was imposed when we selected individuals for fatty acid
analysis of cord sera.
Phospholipid composition in cord serum of individuals
with respiratory allergy or atopic eczema at 13 years of
age, compared to non-allergic controls
Phospholipids were extracted from stored cord serum samples of
individuals representing the three diagnostic groups (respiratory
allergy, atopic eczema and non-allergic, respectively) and the
proportions of long-chain polyunsaturated fatty acids (LCPUFA),
monounsaturated and saturated fatty acids in these phospholipids
were analysed. The results are shown in Table 2. Cord serum
Table 1. Characteristics of the individuals in the selected study groups, the clinical groups from which they were selected and the
cohort from which they derived.
Respiratory allergy{ Atopic eczema* Non-allergic
All participants
in cohort at 13
years of age
Selected Whole group Selected Whole group Selected Whole group
(N=44) (N=130) (N=37) (N=79) (N=48) (N=332) (N=834)
Female sex 33 33 70 70 62 56 50
Older siblings¤ 59 65 59 58 65 60 62
Exclusively breast-fed at 4 months¤ 70 73 74 78 72 71 72
Maternal allergy 1 61 55 49 52 31 33 43
Asthma 25 17 21 23 4 6 14
Rhinitis 43 33 21 24 12 11 20
Eczema 32 32 35 38 23 23 28
Paternal allergy1 51 48 35 37 31 32 36
Asthma 16 16 8 8 10 11 12
Rhinitis 40 32 16 19 17 15 20
Eczema 21 19 24 25 6 16 18
Cat during 1st year of life¥ 14 12 24 23 23 19 19
Dog during 1st year of life¥ 18 16 30 29 21 30 28
Urban residence ¥ 69 62 67 65 61 56 58
{Fulfilling at least one of the following criteria; wheeze in the past year, asthma inhalation treatment, or an affirmative answer to the question: ‘‘Have you had any signs
of pollen allergy or allergy to furred pets during the last 12 months?’’, diagnosed at 13 years of age. *Defined as a pruritic, chronic or chronically relapsing non-infectious
dermatitis with typical features and distribution and fulfilling at least three of the main criteria defined by Hanifin and Rajka [22], diagnosed at 13 years of age.
¤Response to questionnaire distributed at 1 year of age. 1Defined as an affirmative answer to the question ‘‘Has the child’s mother/father ever had asthma, hay fever or
eczema?’’ answered at 13 years of age. ¥Answered at 4 years of age.
doi:10.1371/journal.pone.0067920.t001
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phospholipids from individuals who had developed allergy by age
13 had higher proportions of 5/8 of the examined LCPUFAs
compared to individuals who were non-allergic by age 13. This
included the n-3 PUFAs docosapentaenoic acid (DPA) and
docosahexaenoic acid (DHA), as well as the n-6 PUFAs
arachidonic acid (AA), docosadienoic acid (22:4 n-6) and 20:2 n-
6 (Table 2). In accordance, the proportion of total n-3 LCPUFA,
total n-6 LCPUFA or total LCPUFA were all higher in cord sera
of individuals who had respiratory allergy (p,0.001 for all
comparisons) or atopic eczema (p,0.001 for all comparisons),
compared to those who were non-allergic. Cord serum from
individuals who remained non-allergic at 13 years of age instead
contained higher proportions of the saturated fatty acid 20:0 and
the monounsaturated fatty acid oleic acid (18:1 n-9). They also had
a higher proportion of total MUFA than individuals with
respiratory allergy (p,0.001) or atopic eczema (p,0.001).
N-3 and n-6 PUFAs may have both similar and unique effects
on early immune development. The ratio of total n-6 over total n-
3 LCPUFA in cord serum phospholipids was calculated for each
individual and compared between the groups. Non-allergic
individuals had a higher n-6/n-3 ratio than both individuals with
respiratory allergy and atopic eczema (Table 2). This suggested
that, although both n-3 and n-6 PUFAs were associated with
allergy development, n-3 LCPUFAs had the stronger effect.
Cord serum LCPUFA in relation to maternal allergy
As allergic infants tend to be born to allergic mothers, and since
LCPUFAs in cord blood derive from the mother, maternal allergy
could be a confounding factor affecting both allergy and LCPUFA
levels in the offspring. We therefore split the individuals according
to maternal allergy and examined the relation between LCPUFA
and allergy both in children of non-allergic mothers (n = 54) and
allergic mothers (n = 75). Figure 1 shows that, irrespective of
allergy in the mother, individuals who were allergic by age 13 had
higher proportion of n-3 LCPUFA (Fig. 1a) as well as n-6
LCPUFA (Fig. 1b) in cord serum phospholipids. Conversely,
individuals who developed allergy had lower proportions of
MUFA than those who remained non-allergic, irrespective of
allergy in the mother (Fig 1c).
Dose-response relation between cord LCPUFA and risk of
being allergic at 13 years of age
A dose-response between cord serum phospholipid LCPUFA
proportions and the risk of being allergic by age 13 would
strengthen the assumption that high proportions of LCPUFA in
the cord serum would be causally related to allergy development.
We stratified the 129 subjects into quartiles according to their
proportions of n-3 LCPUFA, n-6 LCPUFA, total LCPUFA, and
MUFA, in cord serum phospholipids. For each quartile, we
determined the proportion of subjects who had respiratory allergy,
atopic eczema, or were non-allergic at 13 years of age. As seen in
Figure 2a, there was a strong positive linear trend between the
proportion of cord serum phospholipids of the n-3 LCPUFA type
and the risk of having respiratory allergy at 13 years of age
(p,0.001). Conversely, there was an equally strong negative
relation between n-3 LCPUFA proportion among cord serum
phospholipids and being non-allergic at 13 years of age (p,0.001,
Fig. 2a). Similarly, the proportion of n-6 LCPUFA in cord serum
phospholipids was also linearly and positively related to having
respiratory allergy at 13 years of age, and inversely related to
being non-allergic at that age (Fig 2b), the same was true of the
proportion of LCPUFA (sum of n-3 and n-6, Fig. 2c). Conversely,
the proportion of MUFA among cord serum phospholipids, were
negatively related to risk of having respiratory allergy by age 13,
but positively related to being non-allergic by that age (Fig 2d).
Atopic eczema at 13 years of age was not significantly dose-
dependently related to either the proportions of LCPUFA or
MUFA in cord serum (Fig 2a–d).
Development of sensitization and allergy with age in
relation to cord LCPUFA
Allergy develops gradually over the years, i.e. early manifesta-
tions, such as eczema and sensitization to food and airborne
allergens, may progress to respiratory allergy, a phenomenon
termed ‘‘the atopic march’’ [26]. Cord blood fatty acid compo-
sition reflects the environment in which the infantile immune
system develops and should, hence, affect the early phases of the
atopic march. As the subjects in the birth-cohort had been
examined regarding sensitization to common allergens by skin
prick tests at 1, 4, and 13 years of age, and regarding allergy
symptoms by questionnaires at 1, 4, 7, and 13 years of age, we
could follow sensitization and allergy development over time in
individuals differing in cord serum fatty acid composition. Kaplan-
Meier analyses were performed after stratification of the subjects
into quartiles according to their proportions of n-3 LCPUFA, n-6
LCPUFA and total LCPUFA, respectively. As seen in Figure 3,
sensitization was more prevalent from one year onwards in the
individuals with the highest proportion of LCPUFA compared to
those with the lowest proportion as shown for n-3, n-6 or total
LCPUFA (Fig 3a–c). Along the same lines, respiratory allergy
developed successively during childhood and at a higher rate in
individuals who had the highest proportion of n-3 LCPUFA
(Fig 3d), n-6 LCPUFA (Fig 3e), or total LCPUFA (Fig. 3f) in cord
serum. Kaplan-Meier analysis failed to reveal a significant relation
between LCPUFA proportion in cord serum and development of
atopic eczema (Fig. 3g–i).
Cox regression analyses were used to control for confounders.
We used the multivariate method PLS to identify confounders for
each of the clinical entities. Figure S1, shows the result of the PLS
regression model with respiratory allergy as = y and total
LCPUFA, as well as potential confounders, as X variables.
Confounders that were found significant in this model were; sex
(p,0.001), maternal allergy (p = 0.029) and paternal allergy
(p = 0.048). Breastfeeding for at least 4 months (p = 0.332), having
pets during the first year of life (p = 0.251), pregnancy length
(p = 0.232), maternal levels of total LCPUFAs (p = 0.075) or
having older siblings (p = 0.998) were not significant (Fig. S1).
Based on this information, the P values in Fig. 3 were all adjusted
for sex and parental history of allergy using Cox regression. Thus,
Kaplan-Meier curves with Cox regression to control for significant
confounders revealed that development of sensitization to com-
mon environmental allergens and respiratory allergy over the first
13 years of life was strongly significantly positively related to the
proportion of LCPUFA in cord serum phospholipids, while no
significant association could be seen between cord LCPUFA
proportions and development of atopic eczema (Fig. 3).
Contribution of maternal fish intake to serum LCPUFA in
mother and infant
As the newborn infant derives its fatty acids from the maternal
circulation, maternal intake of food rich in certain LCPUFAs
could be reflected in the cord serum of the newborn infant.
Unfortunately, no diet registration was included in the study
protocol. However, in mid-pregnancy, the mothers were asked
about how often they consumed fish, the reason being to detect
whether pregnant mothers avoided food that was, by that time,
considered ‘‘allergenic’’. Fish and other seafoods are the principal
Cord Serum PUFAs Predict Allergy Development
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source of n-3 LCPUFA and Figure 4 shows the relation between
the proportion of such LCPUFAs in maternal serum and the
frequency of fish consumption. Although non-significant, there
was a positive trend relating the pregnant woman’s proportion of
n-3 LCPUFA in serum phospholipids to her intake of fish. The
cord serum of the newborn infants had much higher proportion of
n-3 LCPUFA in the phospholipids compared to the serum of the
mother, i.e. at least three times higher (Fig. 4). Furthermore, the
proportion of n-3 LCPUFA in the infant’s cord serum phospho-
lipids was practically unrelated to maternal fish intake (Fig. 4).
Both these observations are compatible with the active pumping of
LCPUFAs across the placenta from the maternal circulation
against a concentration gradient [19]. The active transport could
explain the lack of significant correlations between individual
species of LCPUFAs in maternal serum and cord serum
phospholipids; only one LCPUFA species showed significant
correlation (22:5 n-3: Rho = 0.30, P = 0.04). In contrast, saturated
fatty acids and MUFAs are thought mainly to reach the foetal
circulation by passive diffusion [27]. Accordingly, we found
moderate correlations between maternal and cord serum phos-
pholipid levels of 18:0 (Rho = 0.39, P = 0.04), and 18:1 n-7
(Rho = 0.46, P = 0.01). Nevertheless, the magnitudes of the
correlation coefficients demonstrate that maternal serum fatty
acid levels are not the major determinant of cord serum
phospholipid fatty acid pattern.
Discussion
The present study demonstrates a strong and significant positive
association between high proportions of long-chain PUFAs in the
phospholipid fraction of cord serum and development of
sensitization and respiratory allergy during the first 13 years of
life. Both n-3 and n-6 LCPUFA proportions were positively
associated with allergy development, while the proportion of
monounsaturated fatty acids, MUFA, was inversely related to
sensitization and allergy development. The effect persisted after
controlling for potential confounders, such as parental allergy and
sex, and both n-3 and n-6 LCPUFA proportions dose–depen-
dently increased the risk for developing respiratory allergy. The
strongest predictor for development of sensitization and respira-
tory allergy was the proportion of total LCPUFA in cord serum
phospholipids, i.e. the sum of LCPUFAs of the n-3 and n-6 series.
However, the fact that the ratio of n-6 over n-3 LCPUFA in cord
serum phospholipids was higher in individuals who were non-
allergic by age 13 than in those who were allergic by that age,
suggests that n-3 LCPUFAs might, if anything, be more prone to
support allergy development.
The milieu that surrounds the immune system may modulate
immune responsiveness. Lymph nodes are embedded in perinodal
adipose tissue whose fatty acid composition might impact on the
local immune function [28]. As most data point to a crucial
importance of the very early period of life as decisive for immune
modulation and, hence, allergy development, we consider it
relevant to examine the fatty acid composition of cord serum as to
represent the milieu in which the infant immune system
encounters the first immunostimulatory events. After birth the
foetus is exposed to exogenous microbes and the immature
immune system is activated. Many observations, summarized as
the hygiene hypothesis [29,30] suggest that early microbial
exposure protects against allergy development. Thus, poverty
[31], large families [29], early day care [32], exposure to farm
animals [33] and pets [34], have all been linked to reduced risk of
allergy development. The same is true of exposure to orofaecal
microbes [35,36], to a gut microbiota containing a wide variety of
different bacterial types [3,37] and to parents’ salivary microbes
[38]. The fatty acid milieu in which this immune stimulation takes
place may affect the outcome of this stimulation.
The immune modulatory effects of PUFAs have been studied
extensively. Both n-3 and n-6 PUFAs and their metabolites are
immunosuppressive in that they reduce T-cell activation and
signalling [8–10,13,17,18] as well as production of interferon-
gamma by T-cells [11,12]. n-3 LCPUFAs often show somewhat
stronger effect in dampening T-lymphocyte proliferation. This is
in accordance with our findings that, although both n-6 and n-3
LCPUFAs were positively associated with allergy development, the
effect seemed particularly pronounced for the n-3 LCPUFAs. In
the presence of high-levels of LCPUFA in serum and body fluids,
T-cell activation and proliferation are likely to be blunted and this
may hamper the immune maturation needed to develop
physiologic tolerance to harmless environmental antigens, ‘‘aller-
gens’’. Notably, LCPUFAs foremost target Th1 cells [39–42],
which are activated by microbial exposure [43], while Th2 cells,
Figure 1. Cord serum phospholipid proportions of n-3 LCPUFA,
n-6 LCPUFA and MUFA and allergy at 13 years. The figure shows
the proportion of (a) n-3 long-chain polyunsaturated fatty acids
(LCPUFAs), (b) n-6 LCPUFAs, and (c) total MUFAs in cord serum
phospholipids in the three groups, respiratory allergy (filled), atopic
eczema (hatched) or non-allergic (unfilled), for all subjects (n = 129, left),
subjects born to non-allergic mothers (n = 54, middle) as wells as
subjects born to allergic mothers (n = 75, right). Mann-Whitney U test
were used to test for significant differences between the allergic groups
and the non-allergic group, *P,0.05, **P,0.01, ***P,0.001.
doi:10.1371/journal.pone.0067920.g001
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that are central in IgE-mediated allergy, are not suppressed by
either n-3 or n-6 PUFAs to the same extent [12]. Accordingly,
high levels of either n-3 EPA or n-6 AA in cord serum were shown
to attenuate immunologic responses of cord blood cells to in vitro
stimulation, particularly allergen-stimulated lymphocyte prolifera-
tion and IFN-c production [44].
The proportion of total monounsaturated fatty acids (MUFAs)
correlated negatively with allergy development in a dose-response
fashion. The proportion of total MUFA also correlated negatively
with the proportion of total n-3 LCPUFA and total n-6 LCPUFA
in cord serum phospholipids. We can therefore not distinguish
whether LCPUFAs enhance allergy development, or whether
MUFAs exert a protective effect. Regarding effects on the immune
system, most focus has been on PUFAs, while MUFAs have been
little studied. However, according to current understanding,
MUFAs have no dramatic effects on inflammation or immune
function (as reviewed by Galli and Calder [45] and Yaqoob [46]).
We are aware of only two prior studies that have examined the
relationship between cord serum fatty acid pattern and subsequent
sensitization or allergy development [47,48]; both found no
significant associations, although Duche´n et al. [48] found higher
proportions of 22:4 n-6 and 22:5 n-6 in serum collected at three
months old atopic infants compared with non-atopic infants. The
lack of significant findings in these two studies might be related to
the relatively short follow-up times (18 months [48] and 3 years
[47]). Yu and Bjo¨rkste´n [49] found higher levels of arachidonic
acid, eicosapentaenoic acid (EPA), DHA, 22:4 n-3, and total n-3
PUFAs in cord serum of infants of allergic mothers compared with
infants of non-allergic mothers; the same findings were made by
us. MUFA levels in cord blood in relation to allergy have, to our
knowledge, not been reported.
A few randomized trials have been conducted in which
pregnant women have been given n-3 LCPUFA with the purpose
of reducing allergy development in their offspring [50–54]. Three
of these studies have too short observation time to draw any firm
conclusions regarding allergy development. Of note, they have
also not included any group not receiving any PUFA. Dunstan
et al. [50] gave 52 pregnant women 4 gram fish oil per day from
Figure 2. Developing different allergic manifestations as a function of fatty acid proportions in cord serum phospholipids. The 129
investigated individuals were divided into quartiles according to their proportions of(a) n-3 long-chain polyunsaturated fatty acids (LCPUFAs), (b) n-6
LCPUFAs, (c) total LCPUFAs and (d) total MUFAs in cord serum phospholipids and the proportion within each quartile that had respiratory allergy
(filled), atopic eczema (hatched) or were non-allergic (unfilled) is depicted. P value for trend analysis (Ptrend) is shown for each allergic manifestation.
doi:10.1371/journal.pone.0067920.g002
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gestational week 20 until delivery, while the control group (n = 46)
received the same amount of olive oil. No significant effect of fish
oil supplementation was seen for clinical allergy at one year of age.
Similarly, Furuhjelm et al. published two follow-ups [51,52] on a
randomized control trial were pregnant and lactating women
received either fish oil (n = 52) or n-6 PUFA rich soy oil (n = 65)
from gestational week 25 until 3–4 month postpartum. No
difference in the prevalence of allergic symptoms was found
between the intervention groups at one year of age. Palmer et al.
[54] gave pregnant women fish oil or vegetable oil capsules
containing considerable amount of n-6 PUFA from gestation
week 21 until birth. No effects on clinical allergy were seen at one
year of age. Only one study has allowed sufficient time for
adequate diagnosis of allergic disease; Olsen et al. [53] gave
pregnant women either fish oil, olive oil, or no oil capsules from
gestational week 30 until birth. Asthma and eczema, as well as
total allergy were assessed at 16 years of age. The olive oil group
had the highest incidence of allergy. Both the fish oil and no oil
groups had similar low allergy incidence at 16 years of age, albeit
it was actually lowest in the no-oil group. Hence, compared to no
oil supplementation, fish oil supplementation during pregnancy
did not reduce allergy in the offspring.
The active pumping of PUFAs, particularly DHA, across the
placenta to the foetus was clearly evident in our study from the fact
that while n-3 PUFAs constituted 1–2% of maternal phospholip-
ids, they made up 4–6% of the cord phospholipids. Furthermore,
for most of the investigated fatty acids, we found no correlation
between the levels in maternal and infant sera. Among the
LCPUFA species, only one (22:5 n-3) showed a modest correlation
(0.30). In agreement with the assumption that saturated fatty acids
Figure 3. Cumulative proportion of allergy and sensitization in relation to LCPUFA proportions in cord serum phospholipids. The
129 investigated individuals were divided into quartiles (Q1–Q4) according to their proportions of total n-3 (a–c), total n-6 (d–f), and total long-chain
PUFAs (g–i) among cord serum phospholipids, Q1 representing the lowest and Q4 the highest proportion. Allergy was diagnosed at 1, 4, 7 and
13 years of age and sensitization to a panel of 10 allergens was measured by skin prick test at 1, 4 and 13 years of age. Cox regression was performed
and P values were adjusted for the following confounders: sex, and parental history of allergy.
doi:10.1371/journal.pone.0067920.g003
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and MUFAs mainly diffuse passively into the foetal circulation
[27], we observed moderate correlations between maternal and
cord serum phospholipid levels of 18:0 and 18:1 n-7 (0.39 and
0.46, respectively). Thus, the efficiency by which PUFAs are
transported from the mother to the foetus across the placenta may
be more important for the foetal serum levels than the maternal
levels of LCPUFAs.
Our data are supported by epidemiological studies that have
linked an increased risk of allergy with consumption of margarine,
while consumption of butter is protective; margarine in rich in
PUFAs (mainly n-6 n-6 PUFAs), while butter is rich in saturated
fats [4–7]. Early introduction of fish into the infant’s diet protects
against development of eczema, as shown in several studies [55–
58]. Although this has been interpreted as reflecting a beneficial
effect of n-3 LCPUFA on allergy development, fish contains an
array of other bioactive components that could confer protection
against eczema in early childhood. Also, with one single exception
[55], the beneficial effect of early fish introduction has not been
linked specifically to fatty fish [56–58].
It should be pointed out that our study only examines the
relation between the risk of allergy development and the fatty acid
composition at birth, before activation of the immune system in
response to external stimuli. Once the infant is born and exposed
to exogenous antigens, PUFAs may be consumed in the body.
Hence, in an animal model of allergen-induced sensitisation and
respiratory inflammation, both n-3 and n-6 LCPUFAs in the
serum were rapidly reduced, suggesting that they are consumed
during immune activation and inflammation [59]. This may
explain why already allergic individuals may have reduced
proportions of n-3 LCPUFAs [60].
A limitation of this study is that it is not population based; we
did not analyse fatty acids in all available subjects as these analyses
are quite costly and time-consuming. Instead, we randomly
selected individuals from a population-based cohort encompassing
all vaginally delivered infants born in one hospital during one year.
Selection was based on the diagnosis at 13 years of age and the
selected individuals did not differ with respect to any measured
variables from the rest of the individuals in the same clinical group.
The long follow-up time with repeated skin prick tests and
questionnaires allowed us to study only clearly defined clinical
cases. Interestingly, high proportions of LCPUFAs were strongly
linked to development of sensitization and respiratory allergy,
while there was much less strong evidence of an effect on the other
disease phenotype, i.e. having atopic eczema, but no other allergic
disease manifestation at 13 years of age. This is, admittedly, a
relatively rare phenotype, since atopic eczema tends to wane and
give way to respiratory allergy. Clearly, atopic eczema that persists
into adolescence without concomitant other allergic manifesta-
tions, is not a prototype Th2-driven reaction. Accordingly, only a
minority of the eczematous individuals were sensitized against
common environmental allergens by 13 years of age. In eczem-
atous lesions, Th2 cells dominate early, but are largely replaced by
Th1 cells during the chronic phase and a substantial proportion of
CD8+ T-cells are also seen in the infiltrate [61]. Furthermore,
genetic predisposition may play a greater role in this disease
phenotype than in sensitization and respiratory allergy.
In summary, our study demonstrates a positive dose–response
relationship between levels of both n-3 and n-6 PUFAs in cord
serum and subsequent development of sensitization and respira-
tory allergy. A tentative explanation could be that n-3 and n-6
LCPUFAs counteract T-cell activation in response to microbial
exposure and thereby delay the maturation of the infant’s immune
system that is needed to develop tolerance to innocuous
environmental antigens.
Supporting Information
Figure S1 PLS regression on possible confounding
variables. In a PLS regression model respiratory allergy was
used as the response variable (Y) and the total LCPUFA
proportion in cord serum phospholipids together with confounders
were used as X-variables. The figure shows the weighted
regression coefficients. The striped bars are significant and the
solid bars are non-significant. The error bars represent standard
deviation for the weighted regression coefficients.
(TIF)
Acknowledgments
We thank Nils-Gunnar Carlsson for technical assistance and Anna
Bernholm for blood sampling and performing skin prick tests.
Author Contributions
Conceived and designed the experiments: MB SJ AW ASS AS. Performed
the experiments: MB SJ. Analyzed the data: MB BH. Contributed
reagents/materials/analysis tools: AS. Wrote the paper: MB SJ BH AW
ASS AS.
Figure 4. Correlation between fish intake in pregnancy and n-3
LCPUFA in maternal and cord serum phospholipids at birth. At
gestational week 18 the mothers were asked to specify how often they
consumed fish. These answers were then converted to intake
frequencies in times per month and three groups were formed; one
group eating fish less than twice a month (white bars), one group
eating fish twice a month (light grey bars) and one group eating fish
more than twice a month (dark grey bars). This was then correlated to
the levels of total n-3 LCPUFA in maternal and cord serum
phospholipids at birth.
doi:10.1371/journal.pone.0067920.g004
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